114 related articles for article (PubMed ID: 7895854)
1. Host- and tissue-specific factors that interact with the enhancer sequences of Rous sarcoma virus LTR.
Guntaka RV; Kandala JC; Shin BA; Nambiar A; Svoboda J; Cleavinger P
Folia Biol (Praha); 1994; 40(5):237-47. PubMed ID: 7895854
[No Abstract] [Full Text] [Related]
2. Cloning of Rous sarcoma virus enhancer factor genes. II. RSV-EF-II, abundantly expressed in fibroblasts and muscle tissue, binds to an octamer sequence, 5'-GTACCACC-3', in the noncoding strand of RSV enhancer.
Cleavinger PJ; Shin BA; Kandala JC; Nambiar A; Swamynathan SK; Guntaka RV
Virology; 1996 Aug; 222(1):133-43. PubMed ID: 8806494
[TBL] [Abstract][Full Text] [Related]
3. Cloning of Rous sarcoma virus enhancer factor genes. I. Evidence that RSV-EF-I is related to Y-box (inverted CCAAT) binding proteins and binds to multiple motifs in the RSV enhancer.
Kandala JC; Guntaka RV
Virology; 1994 Feb; 198(2):514-23. PubMed ID: 8291233
[TBL] [Abstract][Full Text] [Related]
4. Factors influencing physiological variations in the activity of the Rous sarcoma virus long terminal repeat.
Lang A; Fincham VJ; Wyke JA
Virology; 1993 Oct; 196(2):564-75. PubMed ID: 8396803
[TBL] [Abstract][Full Text] [Related]
5. Interactions between Marek's disease virus encoded or induced factors and the Rous sarcoma virus long terminal repeat promoter.
Banders UT; Coussens PM
Virology; 1994 Feb; 199(1):1-10. PubMed ID: 8116231
[TBL] [Abstract][Full Text] [Related]
6. Identification of a third protein factor which binds to the Rous sarcoma virus LTR enhancer: possible homology with the serum response factor.
Boulden A; Sealy L
Virology; 1990 Jan; 174(1):204-16. PubMed ID: 2152992
[TBL] [Abstract][Full Text] [Related]
7. [Effect of specific nucleotide sequences on the transcription activity of long terminal repeats of avian retroviruses].
Kraevskiĭ VA; Panin VM; Veretennikov NA
Genetika; 1996 Mar; 32(3):341-7. PubMed ID: 8723626
[TBL] [Abstract][Full Text] [Related]
8. Mutation of the C/EBP binding sites in the Rous sarcoma virus long terminal repeat and gag enhancers.
Ryden TA; de Mars M; Beemon K
J Virol; 1993 May; 67(5):2862-70. PubMed ID: 8386280
[TBL] [Abstract][Full Text] [Related]
9. Identification of three sequence-specific DNA-binding proteins which interact with the Rous sarcoma virus enhancer and upstream promoter elements.
Goodwin GH
J Virol; 1988 Jun; 62(6):2186-90. PubMed ID: 2835519
[TBL] [Abstract][Full Text] [Related]
10. Oncogene and its production of an avian sarcoma virus Y73.
Toyoshima K; Yoshida M; Kawai S; Kitamura N; Yamamoto T; Segawa K
Princess Takamatsu Symp; 1982; 12():275-83. PubMed ID: 6300025
[TBL] [Abstract][Full Text] [Related]
11. Identification of EFIV, a stable factor present in many avian cell types that transactivates sequences in the 5' portion of the Rous sarcoma virus long terminal repeat enhancer.
Houtz EK; Conklin KF
J Virol; 1996 Jan; 70(1):393-401. PubMed ID: 8523553
[TBL] [Abstract][Full Text] [Related]
12. The GT-rich sequence in the U5 region of Rous sarcoma virus long terminal repeat is required for transcription termination and 3' processing.
Cleavinger PJ; Kandala JC; Guntaka RV
Folia Biol (Praha); 1997; 43(4):153-60. PubMed ID: 9338122
[TBL] [Abstract][Full Text] [Related]
13. The upstream, direct repeat sequence of Prague A Rous sarcoma virus is deficient in mediating efficient Gag assembly and particle release.
Simpson SB; Guo W; Winistorfer SC; Craven RC; Stoltzfus CM
Virology; 1998 Jul; 247(1):86-96. PubMed ID: 9683574
[TBL] [Abstract][Full Text] [Related]
14. Cowpox virus contains two copies of an early gene encoding a soluble secreted form of the type II TNF receptor.
Hu FQ; Smith CA; Pickup DJ
Virology; 1994 Oct; 204(1):343-56. PubMed ID: 8091665
[TBL] [Abstract][Full Text] [Related]
15. Completion of avian retroviral DNA replication intermediates inhibited by antisense RNA.
To RY; Booth SC; Turk G; Neiman PE
Virology; 1994 May; 200(2):336-46. PubMed ID: 8178425
[TBL] [Abstract][Full Text] [Related]
16. Exploring the DNA binding interactions of the Kaposi's sarcoma-associated herpesvirus lytic switch protein by selective amplification of bound sequences in vitro.
Ziegelbauer J; Grundhoff A; Ganem D
J Virol; 2006 Mar; 80(6):2958-67. PubMed ID: 16501105
[TBL] [Abstract][Full Text] [Related]
17. CArG, CCAAT, and CCAAT-like protein binding sites in avian retrovirus long terminal repeat enhancers.
Zachow KR; Conklin KF
J Virol; 1992 Apr; 66(4):1959-70. PubMed ID: 1312613
[TBL] [Abstract][Full Text] [Related]
18. Isolation, cloning, and sequencing of simian foamy viruses from chimpanzees (SFVcpz): high homology to human foamy virus (HFV).
Herchenröder O; Renne R; Loncar D; Cobb EK; Murthy KK; Schneider J; Mergia A; Luciw PA
Virology; 1994 Jun; 201(2):187-99. PubMed ID: 8184531
[TBL] [Abstract][Full Text] [Related]
19. Targeting of retroviral integrase by fusion to a heterologous DNA binding domain: in vitro activities and incorporation of a fusion protein into viral particles.
Katz RA; Merkel G; Skalka AM
Virology; 1996 Mar; 217(1):178-90. PubMed ID: 8599202
[TBL] [Abstract][Full Text] [Related]
20. Studies on the 38,000 D putative target protein of the Rous sarcoma virus SRC gene product: association with a cytosolic malic dehydrogenase isoenzyme.
Rübsamen H; Centner P; Eigenbrodt E; Friis RR
Prog Clin Biol Res; 1983; 119():149-57. PubMed ID: 6306684
[No Abstract] [Full Text] [Related]
[Next] [New Search]
